These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 11412407)

  • 1. [Chromosome aberrations in malformed newborns].
    Centeno Malfaz F; Beltrán Pérez A; Ruiz Labarga C; Centeno Robles T; Macías Pardal J; Martín Bermejo M
    An Esp Pediatr; 2001 Jun; 54(6):582-7. PubMed ID: 11412407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Trisomy 21 and abandonment. Infants born and placed for adoption in Paris].
    Dumaret AC; Rosset DJ
    Arch Fr Pediatr; 1993 Dec; 50(10):851-7. PubMed ID: 8053761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Socioeconomic and state-level differences in prenatal diagnosis and live birth prevalence of Down's syndrome in the United States.
    Khoshnood B; Pryde P; Blondel B; Lee KS
    Rev Epidemiol Sante Publique; 2003 Dec; 51(6):617-27. PubMed ID: 14967994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Down's syndrome in a pregnant population in Finland.
    Marttala J; Yliniemi O; Gissler M; Nieminen P; Ryynanen M
    Acta Obstet Gynecol Scand; 2010 May; 89(5):715-7. PubMed ID: 20218932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-natal counselling and diagnosis in Down's syndrome.
    Papp Z
    Med Gynaecol Androl Sociol; 1973; 7(4):10-5. PubMed ID: 12156379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of chromosomal aberrations at birth in the Clinical Hospital of Universidad de Chile, 1990-2001].
    Nazer J; Antolini M; Juárez ME; Cifuentes L; Hubner ME; Pardo A; Castillo S
    Rev Med Chil; 2003 Jun; 131(6):651-8. PubMed ID: 12942593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The association between maternal age and congenital malformations].
    Nazer H J; Cifuentes O L; Aguila R A; Ureta L P; Bello P MP; Correa C F; Melibosky R F
    Rev Med Chil; 2007 Nov; 135(11):1463-9. PubMed ID: 18259659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal use of nutritional supplements during the first month of pregnancy and decreased risk of Down's syndrome: case-control study.
    Czeizel AE; Puhó E
    Nutrition; 2005 Jun; 21(6):698-704; discussion 774. PubMed ID: 15925294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paternal age and birth defects: how strong is the association?
    Yang Q; Wen SW; Leader A; Chen XK; Lipson J; Walker M
    Hum Reprod; 2007 Mar; 22(3):696-701. PubMed ID: 17164268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing.
    Ogilvie CM; Lashwood A; Chitty L; Waters JJ; Scriven PN; Flinter F
    BJOG; 2005 Oct; 112(10):1369-75. PubMed ID: 16167939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down's syndrome in Nigeria: pregnancy wastage in mothers of Down's syndrome.
    Boroffice RA
    Niger Med J; 1979 Jan; 9(1):89-92. PubMed ID: 157014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Structural chromosomal reorganizations and mosaicism in the parents of children with Down's syndrome].
    Butomo IV; Kovaleva NV
    Tsitol Genet; 1993; 27(1):87-91. PubMed ID: 8316960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of Down's syndrome in Sweden during the years 1968-1977.
    Lindsten J; Marsk L; Berglund K; Iselius L; Ryman N; Annerén G; Kjessler B; Mitelman F; Nordenson I; Wahlström J; Vejlens L
    Hum Genet Suppl; 1981; 2():195-210. PubMed ID: 6218136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Paternal age as a risk factor for congenital malformations].
    Nazer H J; Cifuentes O L; Millán Z F; Vacarisas A P; Köbrich Sch S; Aguila R A
    Rev Med Chil; 2008 Feb; 136(2):201-8. PubMed ID: 18483674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
    Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
    Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dermatoglyphics of the relatives of children with congenital defects in development].
    Usoev SS
    Genetika; 1975; 11(2):151-5. PubMed ID: 131740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical diagnosis of Down's syndrome based on 11 signs. Epidemiological analysis of the specificity of the studied signs].
    Martínez-Frías ML; Bermejo Sánchez E; Rodríguez Pinilla E
    An Esp Pediatr; 1996 Nov; 45(5):522-6. PubMed ID: 9036786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic study of Malaysian neonates with congenital abnormalities in Maternity Hospital Kuala Lumpur.
    Norlasiah IS; Clyde MM; Boo NY
    Med J Malaysia; 1995 Mar; 50(1):52-8. PubMed ID: 7752977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
    Lamlertkittikul S; Chandeying V
    J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Factors predisposing to chromosome pathology].
    Zuffardi O; Maraschio P
    Pathologica; 1983; 75 Suppl():96-102. PubMed ID: 6240016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.